Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)

Paul Saultier; Mathieu Simonin; Tiphaine Adam de Beaumais; Fanny Rialland; Fanny Alby-Laurent; Marion Lubnau; Claire Desplantes; Evelyne Jacqz-Aigrain; Pierre Rohrlich; Yves Reguerre; Florence Rabian; Nicolas Sirvent; Genevieve Willson Plat; Arnaud Petit

doi:10.1016/j.bulcan.2022.05.012

Retour

Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)

Article de revue

Avec comité de lecture

Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)

Paul Saultier, Mathieu Simonin, Tiphaine Adam de Beaumais, Fanny Rialland, Fanny Alby-Laurent, Marion Lubnau, Claire Desplantes, Evelyne Jacqz-Aigrain, Pierre Rohrlich, Yves Reguerre, …

Bulletin du cancer, Vol.109(11), pp.1132-1143

01/11/2022

DOI: https://doi.org/10.1016/j.bulcan.2022.05.012

PMID: 35863954

Résumé

Life Sciences & Biomedicine

Oncology

Science & Technology

Maintenance therapy is the last phase of treatment for acute lymphoblastic leukemia in children and adolescents. Although maintenance therapy is associated with toxicities and specific ma-nagement issues, it is an essential phase of treatment that reduces the risk of relapse. The objective of this work is to propose a guide for the initiation, administration, and monitoring of maintenance therapy, and for the management of food, schooling, leisure, community life, risk of infection and links with family medicine.

Indicateurs

1 Consultations de la notice

Détails

Titre: Practical management during maintenance therapy of pediatric acute lymphoblastic leukemia: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)
Créateurs - sans rôle: Paul Saultier - Assistance Publique Hôpitaux de Marseille
Mathieu Simonin - Assistance Publique – Hôpitaux de Paris
Tiphaine Adam de Beaumais - Hop St Louis, AP HP, Dept Pharmacol & Pharmacogenet, Paris, France
Fanny Rialland - CHU Nantes, Serv Oncohematol Pediat, Nantes, France
Fanny Alby-Laurent - Sorbonne Univ, Hop Armand Trousseau, AP HP, Serv Hematol & Oncol Pediat, Paris, France
Marion Lubnau - CHU Nancy, Serv Oncohematol Pediat, Nancy, France
Claire Desplantes - CHU Dijon, Serv Hematooncol Pediat, Dijon, France
Evelyne Jacqz-Aigrain - Hop St Louis, AP HP, Dept Pharmacol & Pharmacogenet, Paris, France
Pierre Rohrlich - CHU Nice, Serv Hematol Pediat, Nice, France
Yves Reguerre - CHU Reunion, Serv Hematooncol Pediat, Reunion, France
Florence Rabian - Assistance Publique – Hôpitaux de Paris
Nicolas Sirvent - CHU Montpellier, Serv Hematol & Oncol Pediat, Montpellier, France
Genevieve Willson Plat - CHU Toulouse, Serv Hematol Oncol & Immunol Pediat, Toulouse, France
Arnaud Petit - Sorbonne Univ, Hop Armand Trousseau, AP HP, Serv Hematol & Oncol Pediat, Paris, France
Détails de publication: Bulletin du cancer, Vol.109(11), pp.1132-1143
Éditeur: Elsevier
Nombre de pages: 12
Identifiants: 99148864909311
Unité académique: Recherche hors université
Langue: English; French
Type de ressource: Journal article